ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,929.60
      -2.20%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.94
      -1.54%
      Bitcoin
      60,212.11
      -5.67%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lyell Immunopharma Inc (LYEL)

      7. Lyell Immunopharma Inc (LYEL) News

      LYEL Lyell Immunopharma Inc

      2.17
      -0.08 (-3.56%)
      After Hours
      Last Updated: 16:02:01
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Lyell Immunopharma Inc LYEL NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.08 -3.56% 2.17 16:02:01
      Open Price Low Price High Price Close Price Prev Close
      2.23 2.16 2.255 2.17 2.25
      more quote information »

      Recent News

      Date Time Source Heading
      4/30/20248:53IHNWFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      3/05/202416:30GLOBELyell Immunopharma Announces the Acceptance of Three..
      2/28/202416:07EDGAR2Form 8-K - Current report
      2/28/202416:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
      2/26/202416:05GLOBELyell Immunopharma Announces Participation in March Investor..
      2/13/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202420:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202420:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202416:05GLOBELyell Immunopharma to Participate in 42nd Annual J.P. Morgan..
      11/20/202320:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/20/202320:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/20/202320:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/20/202316:26EDGAR2Form 8-K - Current report
      11/09/202316:05GLOBELyell Immunopharma Receives FDA Orphan Drug Designation for..
      11/07/202316:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/07/202316:08EDGAR2Form 8-K - Current report
      11/07/202316:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
      10/31/202309:00GLOBELyell Immunopharma Presentations at SITC Highlight New..
      9/27/202309:00GLOBELyell Immunopharma Announces the Acceptance of Six Abstracts..
      9/11/202309:16EDGAR2Form 8-K - Current report
      9/11/202308:00PRNUSCellares and Lyell to Evaluate Automated Manufacturing of..
      8/31/202316:05GLOBELyell Immunopharma to Participate in Upcoming Investor..
      8/08/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/08/202316:10EDGAR2Form 8-K - Current report
      8/08/202316:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
      7/05/202316:05GLOBELyell Immunopharma Appoints Matthew Lang as Chief Business..
      6/07/202316:05GLOBELyell Immunopharma to Participate in the Goldman Sachs..
      5/04/202316:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
      5/02/202316:05GLOBELyell Immunopharma to Participate in BofA Securities..

      Your Recent History

      NASDAQ
      LYEL
      Lyell Immunopharma
      Delayed Upgrade Clock